15 March 2024 in European Radiology
Objectives: To evaluate the performance of multiparametric neurite orientation dispersion and density imaging (NODDI) radiomics in distinguishing between glioblastoma (Gb) and solitary brain metastasis (SBM). Materials and methods: In this retrospective study, NODDI images were curated from 109 patients with Gb (n = 57) or SBM (n = 52). Automatically segmented multiple volumes of interest (VOIs) encompassed the main tumor regions, including necrosis, solid tumor, and peritumoral edema. Radiomics features were extracted for each main tumor region, using three NODDI parameter maps. Radiomics models were developed based on these three NODDI parameter maps and their amalgamation to differentiate between Gb and SBM. Additionally, radiomics models were constructed based on morphological magnetic resonance imaging (MRI) and diffusion imaging (diffusion-weighted imaging [DWI]; diffusion tensor imaging [DTI]) for performance comparison. Results: The validation dataset results revealed that the performance of a single NODDI parameter map model was inferior to that of the combined NODDI model. In the necrotic regions, the combined NODDI radiomics model exhibited less than ideal discriminative capabilities (area under the receiver operating characteristic curve [AUC] = 0.701). For peritumoral edema regions, the combined NODDI radiomics model achieved a moderate level of discrimination (AUC = 0.820). Within the solid tumor regions, the combined NODDI radiomics model demonstrated superior performance (AUC = 0.904), surpassing the models of other VOIs. The comparison results demonstrated that the NODDI model was better than the DWI and DTI models, while those of the morphological MRI and NODDI models were similar. Conclusion: The NODDI radiomics model showed promising performance for preoperative discrimination between Gb and SBM. Clinical relevance statement: The NODDI radiomics model showed promising performance for preoperative discrimination between Gb and SBM, and radiomics features can be incorporated into the multidimensional phenotypic features that describe tumor heterogeneity. Key Points: • The neurite orientation dispersion and density imaging (NODDI) radiomics model showed promising performance for preoperative discrimination between glioblastoma and solitary brain metastasis. • Compared with other tumor volumes of interest, the NODDI radiomics model based on solid tumor regions performed best in distinguishing the two types of tumors. • The performance of the single-parameter NODDI model was inferior to that of the combined-parameter NODDI model.
14 December 2023 in BMC Cancer
Background: We created discriminative models of different regions of interest (ROIs) using radiomic texture features of neurite orientation dispersion and density imaging (NODDI) and evaluated the feasibility of each model in differentiating glioblastoma multiforme (GBM) from solitary brain metastasis (SBM). Methods: We conducted a retrospective study of 204 patients with GBM (n = 146) or SBM (n = 58). Radiomic texture features were extracted from five ROIs based on three metric maps (intracellular volume fraction, orientation dispersion index, and isotropic volume fraction of NODDI), including necrosis, solid tumors, peritumoral edema, tumor bulk volume (TBV), and abnormal bulk volume. Four feature selection methods and eight classifiers were used for the radiomic texture feature selection and model construction. Receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic performance of the models. Routine magnetic resonance imaging (MRI) radiomic texture feature models generated in the same manner were used for the horizontal comparison. Results: NODDI-radiomic texture analysis based on TBV subregions exhibited the highest accuracy (although nonsignificant) in differentiating GBM from SBM, with area under the ROC curve (AUC) values of 0.918 and 0.882 in the training and test datasets, respectively, compared to necrosis (AUCtraining:0.845, AUCtest:0.714), solid tumor (AUCtraining:0.852, AUCtest:0.821), peritumoral edema (AUCtraining:0.817, AUCtest:0.762), and ABV (AUCtraining:0.834, AUCtest:0.779). The performance of the five ROI radiomic texture models in routine MRI was inferior to that of the NODDI-radiomic texture model. Conclusion: Preoperative NODDI-radiomic texture analysis based on TBV subregions shows great potential for distinguishing GBM from SBM.
19 September 2025 in American Journal of Neuroradiology
BACKGROUND AND PURPOSE: Predicting the final location and volume of lesions in acute ischemic stroke (AIS) is crucial for clinical management. While CT perfusion (CTP) imaging is routinely used for estimating lesion outcomes, conventional threshold-based methods have limitations. We developed specialized outcome prediction deep learning models that predict infarct core in successful reperfusion cases and the combined core-penumbra region in unsuccessful reperfusion cases. MATERIALS AND METHODS: We developed single-modal and multi-modal deep learning models using CTP parameter maps to predict the final infarct lesion on follow-up diffusion-weighted imaging (DWI). Using a multi-center dataset from multiple sites, deep learning models were developed and evaluated separately for patients with complete recanalization (CR, successful reperfusion, n=350) and no recanalization (NR, unsuccessful reperfusion, n=138) after treatment. The CR model was designed to predict the infarct core region, while the NR model predicted the expanded hypoperfused tissue encompassing both core and penumbra regions. Five-fold cross-validation was performed for robust evaluation. RESULTS: The multi-modal 3D nnU-Net model demonstrated superior performance, achieving mean Dice scores of 35.36% in CR patients and 50.22% in NR patients. This significantly outperformed the current clinical used method, providing more accurate outcome estimates than the conventional single-modality threshold-based measures which yielded dice scores of 15.73% and 39.71% for CR and NR groups respectively. CONCLUSIONS: Our approach offered both successful reperfusion and unsuccessful reperfusion estimations for potential treatment outcomes, enabling clinicians to better evaluate treatment eligibility for reperfusion therapies and assess potential treatment benefits. This advancement facilitates more personalized treatment recommendations and has the potential to significantly enhance clinical decision-making in AIS management by providing more accurate tissue outcome predictions than conventional single-modality threshold-based approaches. ABBREVIATIONS: AIS=acute ischemic stroke; CR=complete recanalization; NR=no recanalization; DT=delay time; IQR=interquartile range; GT=ground truth; HD95=95% Hausdorff distance; ASSD=average symmetric surface distance; MLV=mismatch lesion volume.